Woojung Bio Inc
215380
Company Profile
Business description
Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.
Contact
Gwanggyo-ro 145, B-dong 3rd Floor
Next Generation Convergence Technology Research Center
Gyeonggi-do, Yeongtong-gu
Suwon-si
KORT: +82 318889369
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
151
Stocks News & Analysis
stocks
Ask the analyst: How reliant are Guzman shares on international growth?
A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,006.80 | 116.00 | 1.30% |
| CAC 40 | 7,833.07 | 11.07 | 0.14% |
| DAX 40 | 24,335.90 | 35.03 | -0.14% |
| Dow JONES (US) | 44,427.17 | 57.32 | -0.13% |
| FTSE 100 | 8,979.04 | 6.40 | 0.07% |
| HKSE | 24,825.66 | 326.71 | 1.33% |
| NASDAQ | 20,946.95 | 61.30 | 0.29% |
| Nikkei 225 | 39,819.11 | 82.08 | -0.21% |
| NZX 50 Index | 12,880.40 | 25.01 | -0.19% |
| S&P 500 | 6,308.92 | 11.56 | 0.18% |
| S&P/ASX 200 | 8,757.20 | 118.20 | 1.37% |
| SSE Composite Index | 3,534.48 | 17.66 | 0.50% |